Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 1, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

July 1, 2023

Conditions
Medication AdherenceRenal Transplant
Interventions
COMBINATION_PRODUCT

Conversion to Envarsus-XR and use of smart phone app, TransMedAx

"Convert to tacrolimus extended release (Envarsus XR) prescribed dose every 24 hours used in combination with the smart phone application, TransMedAx.~Patients in this arm will be trained to use the app along with conversion to Envarsus-XR. Once patient scan the code on medicine bottle and the app will remind them about the time and dose of the medication in their native language."

DRUG

Convert to Envarsus XR once daily

Convert from tacrolimus immediate release to tacrolimus extended release (Envarsus XR) prescribed dose every 24 hours

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Veloxis Pharmaceuticals

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER